Relation
Immunogenicity Outcomes for the Inactivated Whole Virus Vaccine by Wuhan Institute of Biological Products Phase II Trial
Effectiveness of immunogenicity was assessed by measuring the geometric mean titer of neutralizing antibody to live SARS-CoV-2, and the geometric mean titer of specific IgG antibody to whole SARS-CoV-2 antigen.
- Neutralizing Antibody Outcomes
- Specific IgG Antibody Outcomes
0
1
Updated 2020-10-16
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences